Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 18,880 NVAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| Jun 22, 2026 | MAXCYTE, INC. (MXCT) | Grant/Award | 30,421 | n/a |
| Jun 11, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 70,000 | n/a |
| Mar 20, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase | 70,000 | $98.0K |
| Aug 13, 2025 | MAXCYTE, INC. (MXCT) | Purchase | 80,000 | $111.0K |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 23, 2025 | MAXCYTE, INC. (MXCT) | Grant/Award | 29,210 | n/a |
| Jun 14, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| Jun 12, 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 62,728 | n/a |
| Jun 14, 2024 | NOVAVAX INC (NVAX) | Exercise/Conversion | 6,670 | n/a |